drugset / Trial / NCT01559831
Immune Response in IXIARO Batch JEV09L37 Recipients Before and After Revaccination
NaSingle-groupOpen-label
Summary
IC51-319 is a single-arm, open-label study that investigates immune responses in subjects undergoing revaccination after receiving the subpotent batch of IXIARO JEV09L37 during primary immunization.
Timeline
- Start
- 2012-06
- Primary completion
- 2012-12
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IC51 | Vaccine | 0.5 ml | Intramuscular |